Detail Information of Post-Translational Modifications
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0190 Transporter Info | ||||
Gene Name | SLC25A29 | ||||
Transporter Name | Mitochondrial ornithine transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Post-Translational Modification of This DT | |||||
Overview of SLC25A29 Modification Sites with Functional and Structural Information | |||||
Sequence |
MALDFLAGCA GGVAGVLVGH PFDTVKVRLQ VQSVEKPQYR GTLHCFKSII KQESVLGLYK
GLGSPLMGLT FINALVFGVQ GNTLRALGHD SPLNQFLAGA AAGAIQCVIC CPMELAKTRL QLQDAGPART YKGSLDCLAQ IYGHEGLRGV NRGMVSTLLR ETPSFGVYFL TYDALTRALG CEPGDRLLVP KLLLAGGTSG IVSWLSTYPV DVVKSRLQAD GLRGAPRYRG ILDCVHQSYR AEGWRVFTRG LASTLLRAFP VNAATFATVT VVLTYARGEE AGPEGEAVPA APAGPALAQP SSL |
||||
PTM type |
X-Phosphorylation
X-Ubiquitination
X: Amino Acid
|
Phosphorylation |
|||||
---|---|---|---|---|---|
Serine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A29 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
48 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A29 Serine 48 has the potential to affect its expression or activity. | ||||
Threonine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A29 | [2] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
70 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLC25A29 Threonine 70 has the potential to affect its expression or activity. | ||||
Ubiquitination |
|||||
Lysine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLC25A29 | [3] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Lysine |
Modified Location |
36 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Ubiquitination at SLC25A29 Lysine 36 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.